top of page


Pioneering animal healthcare through collaborative clinical trials
We are proud to share that our COO, Rebecca Stjernberg Bejhed, recently visited one of our partnering hospitals to oversee the progress...
Sep 20, 2024


Interlinked selected for the 2024 Innovate Nordics Acceleration Program
Interlinked selected for the 2024 Innovate Nordics Acceleration Program
Sep 12, 2024


Interlinked expands global healthcare collaborations: fostering connections in china
Interlinked expands global healthcare collaborations: fostering connections in china
Aug 30, 2024


ReLink achieves registered trademark status in India, strengthening global commitment to patient safety
ReLink achieves registered trademark status in India, strengthening global commitment to patient safety
Jun 14, 2024


Rebecca Bejhed Returns from NIVAS Conference with Valuable Insights
Rebecca Bejhed Returns from NIVAS Conference with Valuable Insights
Jun 6, 2024


Exciting Milestone Achieved: FDA Registration for Innovative Healthcare Solution
Interlinked AB has reached a significant milestone with the FDA registration of our innovative solution designed to improve healthcare
Jun 3, 2024


Highlights from an Intensive May at Interlinked AB
As May wraps up, we are thrilled to share some key highlights from an incredibly productive month at Interlinked AB!
May 31, 2024


Reflecting on a fantastic experience at the LSX World Congress
Interlinked CEO Katarina Hedbeck moderates the discussion on Developing Your Clinical Trial Strategy – Meeting Compliance
May 7, 2024


Acknowledging KTH Innovation for their unwavering support
Interlinked thanks KTH Innovation for their steadfast support from the very beginning.
Apr 12, 2024


Reflecting on the HealthTech Investment Conference: Showcasing Innovation and Building Connections
Reflecting on the HealthTech Investment Conference: Showcasing Innovation and Building Connections
Mar 14, 2024


Recognising progress: our intellectual property rights portfolio expands with a new patent
Recognising progress: our intellectual property rights portfolio expands with a new patent
Mar 7, 2024


Tada Group's COO Leads Successful Usability Testing for ReLink Device in Linköping
Tada Group's COO Leads Successful Usability Testing for ReLink Device in Linköping
Feb 1, 2024


Gratitude for Recognition: Reflecting on Our Entrepreneurial Journey
We extend our heartfelt thanks for the recognition and the opportunity to share our journey. We express our gratitude to Dr. Hanadi Al...
Jan 17, 2024


Tada Group Participates in HTC Competition: "Solving X"
Tada Group Participates in HTC Competition: "Solving X"
Nov 24, 2023


Latest patent: This time it is India
Goddess Lakshami came early this year! ✨🪔 This #Diwali, our spirits are soaring even higher as we proudly announce that our...
Nov 9, 2023


We're Health Tech Challengers Finalists!
Exciting news! We're thrilled to share that we've been chosen as finalists in the Health Tech Challengers. This accolade underscores our...
Oct 11, 2023


Official logo of Tada Group & upgraded website
Explore Our Evolution: Welcome to Our Upgraded Website! 🚀 Embark on our journey of growth with the unveiling of our revamped website. 🌟...
Oct 6, 2023


ReLink/LinkUS has entered U.S. clinical trials.
Exciting News! ReLink has entered U.S. clinical trials, rebranded as LinkUS. This milestone is a testament to our commitment to...
Sep 15, 2023

Proud Moment for Tada Group AB: Patent Approval in Mexico
We've done it again! ReLink has secured its patent in Mexico. The photo captures the team celebrating this fantastic news. Let’s maintain...
Sep 1, 2023


Patent update: This time it is Malaysia
As we return from summer, our journey of global innovation continues! We're delighted to share that our ReLink technology has secured a...
Aug 18, 2023
bottom of page